27
Participants
Start Date
May 24, 2018
Primary Completion Date
May 26, 2021
Study Completion Date
June 2, 2022
177Lu-PSMA-R2
radio-ligand therapy
Mount Sinai Hospital School of Medicine, New York
National Institute of Health, Bethesda
John Hopkins University - Kimmel Comp. Cancer Center, Baltimore
University of Wisconsin / Paul P. Carbone Comp Cancer Center, Madison
Tulane Cancer Center Tulance Cancer, New Orleans
Pheonix Molecular Imaging Center, Phoenix
University of California San Francisco, San Francisco
Stanford University Medical Center, Stanford
Yale New Haven Children Hospital, New Haven
Hospital Vall Hebrón, Barcelona
Hospital Universitario 12 de Octubre, Madrid
Lead Sponsor
Advanced Accelerator Applications
INDUSTRY